Deseret Mutual Benefit Administrators’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$251K Buy
4,942
+2,302
+87% +$107K 0.09% 175
2025
Q4
$77.9K Buy
2,640
+382
+17% +$10.4K 0.03% 248
2025
Q3
$58.3K Buy
2,258
+1,130
+100% +$31.5K 0.02% 284
2025
Q2
$31.1K Hold
1,128
0.01% 373
2025
Q1
$32K Buy
1,128
+392
+53% +$13.9K 0.02% 364
2024
Q4
$30.6K Buy
736
+208
+39% +$9.94K 0.02% 374
2024
Q3
$35.3K Buy
528
+87
+20% +$7.99K 0.02% 349
2024
Q2
$52.4K Buy
441
+70
+19% +$8.86K 0.02% 280
2024
Q1
$39.5K Buy
371
+126
+51% +$12.7K 0.02% 328
2023
Q4
$24.4K Buy
245
+42
+21% +$3.53K 0.01% 390
2023
Q3
$21K Buy
203
+117
+136% +$13.1K 0.01% 435
2023
Q2
$10.4K Buy
86
+48
+126% +$6.4K ﹤0.01% 471
2023
Q1
$5.84K Buy
+38
New +$6.27K ﹤0.01% 474

Other funds holding MRNA

Deseret Mutual Benefit Administrators's MRNA Position: Q1 2026 in Review

Deseret Mutual Benefit Administrators increased its Moderna (MRNA) stake by 87% in Q1 2026, buying an estimated $107K and bringing the position to 4,942 shares worth $251K. The position accounts for 0.09% of the portfolio, ranked #175.

Deseret Mutual Benefit Administrators first reported a position in MRNA in Q1 2023 and has held it in 13 quarters since. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Deseret Mutual Benefit Administrators held 4,942 shares of Moderna worth $251K as of Q1 2026.
  • Deseret Mutual Benefit Administrators bought 2,302 Moderna shares in Q1 2026, an estimated $107K.
  • Moderna made up 0.09% of Deseret Mutual Benefit Administrators's portfolio in Q1 2026, its #175 holding.
  • Deseret Mutual Benefit Administrators first reported a position in Moderna in Q1 2023 and has held it in 13 quarters since.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Deseret Mutual Benefit Administrators's 13F filing for Q1 2026, filed 8 May 2026.